Xeno Labs BPC-157 – 5mg

Recommended Dosage:

250-500mcg (0.25-0.5mg) twice daily is standard. Most users inject 250mcg in morning and 250mcg in evening for total 500mcg daily. More severe injuries may use 500mcg twice daily (1mg total daily). Since one vial contains 5mg, it provides 10-20 days of treatment.

Injection Frequency:

Twice daily is optimal due to BPC-157's short half-life (less than 30 minutes). Morning and evening dosing maintains consistent levels. Some users dose once daily for convenience with good results, but twice daily is superior.

When to Inject:

Subcutaneous injection preferred into abdominal fat using insulin needle. Can also inject intramuscularly. Injecting near injury site may enhance local effects, though systemic circulation ensures healing benefits reach all damaged areas. Can be taken orally for gut issues specifically.

Cycle Duration:

4-8 weeks for acute injuries. Chronic conditions may require 8-12+ weeks or multiple cycles. Many users run 4-6 week cycles then assess healing progress. Can be used continuously for chronic issues with breaks every 2-3 months.

Reconstitution:

Mix 5mg powder with 2ml bacteriostatic water. This creates 2.5mg/ml concentration. Each 0.2ml (20 units on insulin syringe) = 500mcg dose. Each 0.1ml (10 units) = 250mcg dose. Gently swirl until dissolved (do not shake).

Most Common:

• Virtually no side effects reported in most users
• Rare: slight fatigue during first few days
• Very rare: mild headache
• Occasional: temporary dizziness

Serious Side Effects:

• No serious side effects documented in research or widespread use
• No hormonal disruption
• No organ toxicity across wide dose ranges
• No withdrawal or dependency

How to Manage:

BPC-157 has exceptional safety profile with essentially no side effects for most users. Stay hydrated. No blood work required. No PCT needed. If any mild symptoms occur, they typically resolve within days.

Active Ingredient: BPC-157 (Body Protection Compound-157) - Synthetic pentadecapeptide
Dosage Strength: 5 milligrams per vial
Quantity: Single vial (requires reconstitution with bacteriostatic water)
Form: Lyophilized (freeze-dried) powder requiring reconstitution before injection

Intended Use:
Primary research use: Tissue healing research, gastrointestinal protection studies, regenerative medicine research.
Primary user applications: Injury recovery (tendons, ligaments, muscles), pain and inflammation reduction, gut health restoration, chronic condition treatment.

Classification: Synthetic pentadecapeptide, tissue healing and protective compound

Mechanism of Action: BPC-157 is a synthetic 15-amino acid peptide derived from body protection compound found in gastric juice. It promotes healing through multiple mechanisms: stimulates angiogenesis (new blood vessel formation) via VEGF receptor activation and nitric oxide pathways; enhances collagen synthesis and fibroblast activity for tissue regeneration; activates growth factor pathways including JAK2 signaling and growth hormone receptors; modulates inflammatory pathways reducing pain and swelling; promotes endothelial cell protection and vascular health; influences nitric oxide production for improved blood flow; supports gut-brain axis communication. Works both locally and systemically to accelerate natural healing processes.

Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.53 g/mol

Half-Life: Less than 30 minutes to 2 hours (requires twice-daily dosing)
Detection Time: Up to 4 days in urine by mass spectrometry
Bioavailability: High via subcutaneous or intramuscular injection; also orally active (unique for peptides)
Aromatization: None - peptide, not steroid
Hepatotoxicity: None - no toxicity to liver, kidneys, or other organs
Effects on Hormones: None - does not affect testosterone, estrogen, or other hormones

Administration: Subcutaneous injection preferred using insulin needle into abdominal fat. Can inject intramuscularly or near injury site. Can be taken orally for gastrointestinal benefits. Reconstitute with 2ml bacteriostatic water before use. Inject slowly.

Storage: Must be refrigerated at 36-46°F (2-8°C) after reconstitution. Store powder at room temperature or refrigerated before reconstitution. Do not freeze. Use within 30 days of reconstitution. Protect from light.

Research History: First described scientifically in 1993 by Croatian scientist Professor Predrag Sikirić. Over 30 years of research primarily conducted in Croatia and Eastern Europe with extensive animal studies and emerging human clinical interest.

Also Known As: BPC 157, Bepecin, PL 14736, PL10, Body Protection Compound